Replies to post #133538 on Amarin Corp Plc (AMRN)

[jfmcrr]

Only disconfirming evidence is the share price with significant volume which I am putting down to simply nervous pre-trial binary action, people who traded this for the run-up exiting, stop losses, consonance selling down, limited understanding that its not fish oil and that reduce-it is not related to ASCEND or VITAL.

This was a phone CC and the last data I had was 100 participants; it was for Slingshot Insights/Stat Plus subscribers. This info will seep into investor consciousness until we get critical mass on STAT/elsewhere.

Do yer part.

[ziploc_1]

Jt......"consonance selling down"

You are probably correct.....I am anxiously waiting to see how many shares of Amarin Consonance sold in Q2......They may soon have regret for selling what they did, although the many millions of shares they have left will be a consolation.

[Whalatane]

Jt. quick note
My issue with the design of R-IT was that they should have enrolled only Category 1 ( prior events ) patients .
That would have increased chances of success..

You are correct in that R-IT is designed to see if 4gms of Vascepa will reduce events in patients with median TG's of around 220 while LDL is controlled below 100.

Thanks to JF , Dude et al for providing notes from CC .
My quick observations .
MD obviously biased ...conflicts of interest ... so take his projections with at least a grain of salt .
So he says ...85% chance for a RRR of between 15-20%
Guess that means that all you thinking there will be a higher RRR then that ...only have a 15% chance of being right.
Kiwi